Rendering

Component: (Network and Table)
Network
100240 - Disclosure - Balance sheet components (Tables)
(http://www.invitae.com/20161231/taxonomy/role/DisclosureBalanceSheetComponentsTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Balance Sheet Related Disclosures [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Balance Sheet Related Disclosures [Abstract]
 
Schedule cash, cash equivalents, short-term investments, and long-term investments

The following is a summary of cash equivalents and marketable securities (in thousands).

 

 

 

December 31, 2016

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Estimated

Fair Value

 

Money market funds

 

$

19,457

 

 

$

 

 

$

 

 

$

19,457

 

U.S. treasury notes

 

 

11,515

 

 

 

2

 

 

 

 

 

 

11,517

 

U.S. government agency securities

 

 

14,283

 

 

 

 

 

 

(2

)

 

 

14,281

 

 

 

$

45,255

 

 

$

2

 

 

$

(2

)

 

$

45,255

 

Reported as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

$

14,760

 

Restricted cash

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,697

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

25,798

 

Total cash equivalents, restricted cash and

   marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

45,255

 

 

 

 

December 31, 2015

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Estimated

Fair Value

 

Money market funds

 

$

39,998

 

 

$

 

 

$

 

 

$

39,998

 

U.S. treasury notes

 

 

4,006

 

 

 

 

 

 

 

 

 

4,006

 

U.S. government agency securities

 

 

65,586

 

 

 

1

 

 

 

(16

)

 

 

65,571

 

 

 

$

109,590

 

 

$

1

 

 

$

(16

)

 

$

109,575

 

Reported as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

$

50,964

 

Restricted cash

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,831

 

Marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

53,780

 

Total cash equivalents, restricted cash and

   marketable securities

 

 

 

 

 

 

 

 

 

 

 

 

 

$

109,575

 

 

 
 
Schedule of Property and equipment

Property and equipment consisted of the following (in thousands):

 

 

 

December 31,

2016

 

 

December 31,

2015

 

Leasehold improvements

 

$

1,256

 

 

$

2,548

 

Laboratory equipment

 

 

13,644

 

 

 

10,461

 

Equipment under capital lease

 

 

5,871

 

 

 

8,224

 

Computer equipment

 

 

2,514

 

 

 

2,397

 

Software

 

 

2,489

 

 

 

2,368

 

Furniture and fixtures

 

 

238

 

 

 

210

 

Automobiles

 

 

20

 

 

 

20

 

Construction-in-progress

 

 

12,229

 

 

 

1,202

 

Total property and equipment, gross

 

 

38,261

 

 

 

27,430

 

Accumulated depreciation and amortization

 

 

(14,468

)

 

 

(8,721

)

Total property and equipment, net

 

$

23,793

 

 

$

18,709

 

 

 
 
Schedule of Accrued liabilities

Accrued liabilities consisted of the following (in thousands):

 

 

 

December 31,

2016

 

 

December 31,

2015

 

Accrued compensation and related expenses

 

$

3,072

 

 

$

2,307

 

Accrued laboratory materials purchases

 

 

338

 

 

 

426

 

Accrued professional services

 

 

446

 

 

 

272

 

Accrued construction in progress

 

 

1,215

 

 

 

 

Lease incentive obligation, current

 

 

468

 

 

 

 

Other

 

 

1,172

 

 

 

1,248

 

Total accrued liabilities

 

$

6,711

 

 

$

4,253

 

 

 
 
Schedule of Other long-term liabilities

Other long-term liabilities consisted of the following (in thousands):

 

 

 

December 31,

2016

 

 

December 31,

2015

 

Lease incentive obligation, non-current

 

$

4,243

 

 

$

107

 

Deferred rent, non-current

 

 

3,419

 

 

 

98

 

Other non-current liabilities

 

 

175

 

 

 

138

 

Total other long-term liabilities

 

$

7,837

 

 

$

343